Alyeska Investment Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-100,000
| Closed | -$1.65M | – | 332 |
|
|
2018
Q3 | $1.65M | Sell |
100,000
-298,717
| -75% | -$4.93M | 0.02% | 293 |
|
|
2018
Q2 | $5.58M | Sell |
398,717
-57,860
| -13% | -$810K | 0.05% | 252 |
|
|
2018
Q1 | $5.05M | Sell |
456,577
-28,004
| -6% | -$309K | 0.04% | 265 |
|
|
2017
Q4 | $4.26M | Sell |
484,581
-75,000
| -13% | -$660K | 0.03% | 253 |
|
|
2017
Q3 | $7.47M | Sell |
559,581
-26,446
| -5% | -$353K | 0.06% | 250 |
|
|
2017
Q2 | $8.41M | Buy |
586,027
+136,027
| +30% | +$1.95M | 0.07% | 241 |
|
|
2017
Q1 | $9.52M | Buy |
+450,000
| New | +$9.52M | 0.08% | 257 |
|
|
2015
Q1 | – | Sell |
-34,183
| Closed | -$558K | – | 472 |
|
|
2014
Q4 | $558K | Buy |
+34,183
| New | +$558K | 0.01% | 413 |
|